Embree Financial Group Novo Nordisk A S Transaction History
Embree Financial Group
- $597 Billion
- Q1 2025
A detailed history of Embree Financial Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Embree Financial Group holds 12,849 shares of NVO stock, worth $918,703. This represents 0.15% of its overall portfolio holdings.
Number of Shares
12,849
Previous 14,062
8.63%
Holding current value
$918,703
Previous $1.21 Billion
26.24%
% of portfolio
0.15%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.35 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.06 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$886 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$881 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$849 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $161B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...